Age-Related Macular Degeneration Market 2018 | By Novartis International AG, Alcon Vision Care, Bayer AG, Etc Global Key Players

The growing awareness of AMD and the increasing geriatric population are anticipated to exhibit more opportunities for the growth of the Age-Related Macular Degeneration Market. Moreover, as per the Community Eye Health Journal published in 2014 by the London School of Hygiene and Tropical Medicine, nearly 196 million people are estimated to suffer from age-related macular degeneration by 2020 worldwide.

The Global Age-Related Macular Degenerations Market is expected to grow at a CAGR of approximately 7.3% during the forecast period.

Macular degeneration is a type of progressive eye disease that causes the loss of central field of vision. In the case of dry age-related macular degeneration, the deterioration of the retina occurs. Furthermore, in case of wet macular degeneration, the growth of leaky blood vessels occur under the retina.

To Explore More, Get PDF Sample Copy @ https://www.marketresearchfuture.com/sample_request/5736 .

Key Players for Global Age-Related Macular Degeneration Market

Some of the key players in the Global Age-Related Macular Degeneration Market are Novartis International AG (Switzerland), Alcon Vision Care (U.S.), Bayer AG (Germany), Acucela Inc. (U.S.), Neurotech Pharmaceuticals Inc. (U.S.), Ophthotech Corporation (U.S.), GlaxoSmithKline Plc (U.S.), Alimera sciences Inc. (U.S.), StemCell Inc. (Canada), F. Hoffmann-La Roche Ltd. (Switzerland), Regeneron Pharmaceutical Inc. (U.S.), Allergan Plc (Ireland), Adverum Biotechnologies Inc. (U.S.), Gilead Sciences Inc. (U.S.), Iconic Therapeutics Inc. (U.S.), Lpath Inc. (U.S.), OHR Pharmaceutical Inc. (U.S.), Bausch + Lomb (U.S.), Opthea Limited (Canada), PanOptica, Inc. (U.S.), Pfizer Inc. (U.S.), Neurotech Pharmaceuticals, Inc. (U.S.), Promedior, Inc. (U.S.), QLT Inc. (Canada), Quark (U.S.), Resolvyx Pharmaceuticals Inc. (U.S.), RXi Pharmaceuticals Inc. (U.S.), Sagent Pharmaceuticals, Inc. (U.S.), Santen Pharmaceutical Co., Ltd. (Japan), Sanwa Kagaku Kenkyusho (Japan), and others.

Segments for Global Age-Related Macular Degeneration Market

The Global Age-Related Macular Degeneration Market is segmented by type, drug, route of administration, treatment, and end-user.

On the basis of type, the Global Age-Related Macular Degeneration Market is segmented into dry age-related macular degeneration and wet age-related macular degeneration

On the basis of drug, the Global Age-Related Macular Degeneration Market is segmented into Eylea, Visudyne, Lucentis, Avastin, and others.

On the basis of route of administration, the Global Age-Related Macular Degeneration Market is segmented into intravenous, intravitreal, and others.

On the basis of treatment, the Global Age-Related Macular Degeneration Market is segmented into medications, devices, surgery, and others. The medication segment is further classified into anti-VEGF drugs, blood vessel growth inhibitors, vitamins, dietary supplements, and others. The devices segment is classified into corrective lens, glasses, contact lenses, and others.

On the basis of end-user, the Global Age-Related Macular Degeneration Market is segmented into hospitals and diagnostic centers, clinics, academic research institutes, pharmaceutical and biotechnology companies, and others
Regional Analysis for Global Age-Related Macular Degeneration Market

The Global Age-Related Macular Degeneration Market consists of four regions such as the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas region accounted for the largest market share of the Global Age-Related Macular Degeneration Market owing to the growing occurrence of age-related macular degeneration in the South American region, eye disorders among the adolescents, and the rising awareness about its long-term effects.

The European region accounted for the second largest market owing to factors such as the rising geriatric population and the increasing prevalence of eye disorders such as stargardt disease, different types of macular degenerations, and diabetic retinopathy.

The Asia Pacific region is anticipated to witness a fast growth during the forecast period for the Global Age-Related Macular Degeneration Market.

The Middle Eastern region is anticipated to grow at a steady pace owing to factors such as growing emphasis on new drug developments, rising R&D activities in the healthcare sector, and extensive development of healthcare infrastructure.

Get Prime Discount on Report https://www.marketresearchfuture.com/check-discount/5736 .

Some Brief Table of Contents of Report

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

TOC Continued…

Do You Have Specific Requirement? Ask To Our Experts@ https://www.marketresearchfuture.com/enquiry/5736 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.